FDA Inspection 1280551 — Jiangxi Fushine Pharmaceutical Co., Ltd.
The FDA completed an inspection of Jiangxi Fushine Pharmaceutical Co., Ltd. on August 14, 2025 in Jing Dezhen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jing Dezhen (China)